Ailurus Bio logo

Ailurus Bio

Programming biology to automate and accelerate science.

17 employees · est. 2022 · London, United Kingdom

VS
Vevo Therapeutics logo

Vevo Therapeutics

We are combining in vivo data and AI to find better targets and drugs that can treat more patients.

25 employees · est. 2022

Side-by-Side Comparison

Ailurus Bio Vevo Therapeutics
Founded
2022 2022
Headquarters
London, United Kingdom Not tracked yet
Employees
17 25
Industry
Biopharma, Biotechnology, Life Sciences AI, Biotechnology, Health and Wellness
Funding Stage
Undisclosed Seed
Total Funding
Not tracked yet $12.00M
Funding Rounds
1 1
Services
PandaPure Protein Systems, Ailurus vec Expression Libraries, Construct Design and Building, Metabolic Engineering Not tracked yet
Target Customers
Researchers, Biodevelopers, Synthetic Biologists, Life Science Companies, Biotechnology Firms, R&D Laboratories Not tracked yet
Taxonomy
Synthetic Biology, Bioengineering, Biological Programming, Molecular Biology, AI Integration, Lab Automation, High-throughput Screening, Biocomputing, Cloud Biocomputation, Genetic Instruction Development, Biological Software, Strain Optimization, Protein Purification, Self-Driving Labs, Biocomputer Architecture In Vivo Data, Drug Discovery, Mosaic Platform, Single-cell Precision, Patient Diversity, In Vivo Atlas, Genomics, Computational Biology, Chemistry, San Francisco, Investors, Life Sciences, Technology
Website
ailurus.bio vevo.ai
Ailurus Bio logo

About Ailurus Bio

Ailurus Bio, founded in 2022 and headquartered in the United Kingdom, is a trailblazer in the Biopharma, Biotechnology, and Life Sciences sectors. The company's mission, encapsulated by its slogan "Programming biology to automate and accelerate science," revolves around transforming lab-grown cells...

Vevo Therapeutics logo

About Vevo Therapeutics

Vevo Therapeutics is a biotechnology startup founded in 2022, with a mission to revolutionize drug discovery using in vivo data and AI. The company's Mosaic platform is pioneering in capturing in vivo context of diseases with single-cell precision, enabling a more accurate representation of patient...

We will tell you when either one moves

BounceWatch watches Ailurus Bio and Vevo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ailurus Bio and Vevo Therapeutics — by email.

Frequently Asked Questions

Ailurus Bio — Programming biology to automate and accelerate science.. Vevo Therapeutics — We are combining in vivo data and AI to find better targets and drugs that can treat more patients.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ailurus Bio has raised undisclosed funding while Vevo Therapeutics has raised $12.00M.
Ailurus Bio and Vevo Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ailurus Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ailurus Bio on 15 Jun 2026, and Vevo Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy